📊 HCTI Key Takeaways
Is HCTI a Good Investment? Thesis Analysis
Healthcare Triangle exhibits severe financial distress with negative operating cash flow of -9.7M annually against only 1.6M cash reserves, providing less than 2 months of runway. The company is persistently unprofitable with -5.3M operating loss and negative returns on equity (-57%) and assets (-35.9%), indicating unsustainable fundamentals despite reported revenue growth from a minimal base.
Why Buy HCTI? Key Strengths
- Exceptional revenue growth of 1064% YoY demonstrates strong top-line momentum
- Low financial leverage with 0.10x debt-to-equity ratio limits solvency risk
- Current ratio of 2.03x indicates adequate short-term liquidity position
HCTI Investment Risks to Consider
- Negative operating cash flow of -9.7M annually with only 1.6M cash provides insufficient runway for operations
- Persistent operating losses (-5.3M) and negative net income (-5.0M) with declining profitability margins (-49.7% operating margin)
- Severely negative returns on equity and assets (-57% and -35.9% respectively) indicate systematic shareholder value destruction
- Critical data quality issues with reported gross profit (1.1B) exceeding revenue (10.8M) by 100x raises concerns about financial reporting reliability
Key Metrics to Watch
- Operating cash flow trend - survival depends on achieving positive cash generation
- Cash balance and monthly burn rate - critical monitoring for liquidity crisis
- Operating income and net income path to profitability - must demonstrate breakeven within current cash runway
HCTI Financial Metrics
💡 AI Analyst Insight
Strong liquidity with a 2.03x current ratio provides a solid financial cushion.
HCTI Profitability Ratios
HCTI vs Technology Sector
How Healthcare Triangle, Inc. compares to Technology sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is HCTI Overvalued or Undervalued?
Based on fundamental analysis, Healthcare Triangle, Inc. has mixed fundamental signals relative to the Technology sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
HCTI Balance Sheet & Liquidity
HCTI 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Healthcare Triangle, Inc.'s revenue has grown significantly by 30% over the 5-year period, indicating strong business expansion. The most recent EPS of $-2.08 indicates the company is currently unprofitable.
HCTI Growth Metrics (YoY)
HCTI Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.4M | -$1.2M | $-0.42 |
| Q2 2025 | $3.0M | -$1.4M | $-0.58 |
| Q1 2025 | $3.7M | -$1.7M | $-0.17 |
| Q3 2024 | $2.4M | -$1.2M | $-0.22 |
| Q2 2024 | $3.0M | -$1.5M | $-0.28 |
| Q1 2024 | $4.1M | -$1.9M | $-0.42 |
| Q2 2023 | $7.8M | -$405.0K | N/A |
| Q1 2023 | $9.8M | -$2.0M | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
HCTI Capital Allocation
HCTI SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Healthcare Triangle, Inc. (CIK: 0001839285)
📋 Recent SEC Filings
❓ Frequently Asked Questions about HCTI
What is the AI rating for HCTI?
Healthcare Triangle, Inc. (HCTI) has an AI rating of STRONG SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are HCTI's key strengths?
Claude: Exceptional revenue growth of 1064% YoY demonstrates strong top-line momentum. Low financial leverage with 0.10x debt-to-equity ratio limits solvency risk.
What are the risks of investing in HCTI?
Claude: Negative operating cash flow of -9.7M annually with only 1.6M cash provides insufficient runway for operations. Persistent operating losses (-5.3M) and negative net income (-5.0M) with declining profitability margins (-49.7% operating margin).
What is HCTI's revenue and growth?
Healthcare Triangle, Inc. reported revenue of $10.8M.
Does HCTI pay dividends?
Healthcare Triangle, Inc. does not currently pay dividends.
Where can I find HCTI SEC filings?
Official SEC filings for Healthcare Triangle, Inc. (CIK: 0001839285) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is HCTI's EPS?
Healthcare Triangle, Inc. has a diluted EPS of $-2.23.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is HCTI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Healthcare Triangle, Inc. has a STRONG SELL rating with 85% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is HCTI stock overvalued or undervalued?
Valuation metrics for HCTI: ROE of -57.0% (sector avg: 22%), net margin of -46.3% (sector avg: 18%). Compare these metrics with sector averages to assess valuation.
Should I buy HCTI stock in 2026?
Our dual AI analysis gives Healthcare Triangle, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is HCTI's free cash flow?
Healthcare Triangle, Inc.'s operating cash flow is $-9.7M, with capital expenditures of $6.0K. FCF margin is -90.2%.
How does HCTI compare to other Technology stocks?
Vs Technology sector averages: Net margin -46.3% (avg: 18%), ROE -57.0% (avg: 22%), current ratio 2.03 (avg: 2.5).